Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications
Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme.
Journal: Diabetes, obesity & metabolism
Published: February 01, 2024
Showing 1-1 of 1
Last Updated: 09/26/2026